Risk of secondary haematological malignancies in patients with follicular lymphoma: an analysis of 1028 patients treated in the rituximab era

Approved

Classifications

MinEdu publication type
A1 Journal article (peer-reviewed)
Name
A1
Category
Artikkeli
Refereed
Kyllä
Sub category
Tieteellinen aikakauslehti
Type
Alkuperäisartikkeli

Authors of the publication

Number of authors
20
Authors
Prusila, Roosa E. I.; Sorigue, Marc; Jauhiainen, Jyrki; Mercadal, Santiago; Postila, Aleksi; Salmi, Petteri; Tanhua, Taru; Tikkanen, Susanna; Kakko, Sakari; Kuitunen, Hanne; Pollari, Marjukka; Nystrand, Ilja; Kuusisto, Milla E. L.; Vasala, Kaija; Jantunen, Esa; Korkeila, Eija; Karihtala, Peeter; Sancho, Juan-Manuel; Turpeenniemi-Hujanen, Taina; Kuittinen, Outi

Publication channel information

Title of journal/series
British journal of haematology
ISSN (print)
0007-1048
ISSN (electronic)
1365-2141
ISSN (linking)
0007-1048
Publication forum ID
52687
Publication forum level
2
Country of publication
United Kingdom
Internationality
Yes

Detailed publication information

Publication year
2019
Reporting year
2019
Journal/series volume number
187
Journal/series issue number
3
Page numbers
364-371
DOI
10.1111/bjh.16090
Language of publication
English

Co-publication information

International co-publication
Yes
Co-publication with a company
No

Availability

Link to online publication
https://doi.org/10.1111/bjh.16090
Link to self-archived version
http://urn.fi/urn:nbn:fi-fe2020051435619

Classification and additional information

MinEdu field of science classification
3122 Cancers
Keywords
follicular lymphoma; late effects of therapy; secondary haematological malignancies; secondary leukaemia; treatment related cancer; follicular lymphoma; late effects of therapy; secondary haematological malignancies; secondary leukaemia; treatment related cancer

Source database ID

WoS ID
WOS:000476206200001
Scopus ID
2-s2.0-85068519068